Amphastar Pharmaceuticals, Inc. — Director's Dealing 2017

Dec 5, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Amphastar Pharmaceuticals, Inc. (AMPH)
CIK: 0001297184
Period of Report: 2017-12-01

Reporting Person: PETERS WILLIAM J (CFO, SVP & Treasurer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-12-01	Common Stock	S	6226	$19.67	Disposed	78314	Direct

Footnotes

F1: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 13, 2017.

F2: Includes an aggregate of 1,044 shares acquired under the Issuer's 2014 Employee Stock Purchase Plan on May 31, 2017 and November 30, 2017.